Search research articles
Contact Us
Filters
Showing results (191-200 of 197) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 197 results.
ESMO Open
|
November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
N Hindi, A Razak, E Rosenbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2024
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B J Monk, M P Barretina-Ginesta, B Pothuri, et al.
Revista Espanola De Salud Publica
|
February 23, 2021
[Beginnings, evolution and current situation of the Newborn Screening Programs in Spain.]
José Luis Marín Soria, José Manuel González de Aledo Castillo, Ana Argudo Ramírez, et al.
Physical Review Letters
|
September 4, 2008
Observation of the suppression of the flux of cosmic rays above 4 x 10 (19) eV
J Abraham, P Abreu, M Aglietta, et al.
Physical Review Letters
|
April 7, 2010
Measurement of the depth of maximum of extensive air showers above 10{18} eV
J Abraham, P Abreu, M Aglietta, et al.
Physical Review Letters
|
June 4, 2008
Upper limit on the diffuse flux of ultrahigh energy tau neutrinos from the Pierre Auger Observatory
J Abraham, P Abreu, M Aglietta, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 197) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 197 results.
ESMO Open
|
November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
N Hindi, A Razak, E Rosenbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 16, 2024
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B J Monk, M P Barretina-Ginesta, B Pothuri, et al.
Revista Espanola De Salud Publica
|
February 23, 2021
[Beginnings, evolution and current situation of the Newborn Screening Programs in Spain.]
José Luis Marín Soria, José Manuel González de Aledo Castillo, Ana Argudo Ramírez, et al.
Physical Review Letters
|
September 4, 2008
Observation of the suppression of the flux of cosmic rays above 4 x 10 (19) eV
J Abraham, P Abreu, M Aglietta, et al.
Physical Review Letters
|
April 7, 2010
Measurement of the depth of maximum of extensive air showers above 10{18} eV
J Abraham, P Abreu, M Aglietta, et al.
Physical Review Letters
|
June 4, 2008
Upper limit on the diffuse flux of ultrahigh energy tau neutrinos from the Pierre Auger Observatory
J Abraham, P Abreu, M Aglietta, et al.
Page
of 20